AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹11 Cr | ₹47 Cr | ₹29 Cr | ₹14 Cr | ₹4.25 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹47 Cr |
Mar2022 | ₹29 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹4.25 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | -75.76 | |
Mar2023 | ₹47 Cr | 60.86 | |
Mar2022 | ₹29 Cr | 108.75 | |
Mar2021 | ₹14 Cr | 230.95 | |
Mar2020 | ₹4.25 Cr | - |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹351.4 Cr | -7.6% | -20% | 2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,461.0 Cr | 1.4% | -4.1% | 32.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,983.0 Cr | -4.2% | -5.1% | 59.6% | Stock Analytics | |
CIPLA | ₹112,735.0 Cr | -2.2% | -7.3% | 0.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,913.9 Cr | -7.1% | -13.8% | 8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,815.0 Cr | -6.4% | -5.2% | 31.2% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -7.6% |
-20% |
2.8% |
SENSEX | -2.2% |
-4% |
5.5% |
You may also like the below Video Courses